skip to Main Content

Scholar Rock Announce New 36-Month Apitegromab Extension Data

Scholar Rock have announced new 36-Month Apitegromab Extension Data which reinforces long-term substantial and sustained improvement of motor function in phase 2 Topaz trial patients with Nonambulatory SMA.

You can read the full press release here.

Back To Top